Skip to main content
CARMAT logo

CARMAT — Investor Relations & Filings

Ticker · ALCAR ISIN · FR0010907956 LEI · 969500ARXACM0P0KH333 PA Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2017-01-25 Board/Management Inform…
Country FR France
Listing PA ALCAR

About CARMAT

https://www.carmatsa.com/en/

CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.

Recent filings

Filing Released Lang Actions
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Board/Management Information Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces the co-option of two new independent members to CARMAT's Board of Directors, replacing two resigning members. This action directly relates to changes in the company's governing body. According to the definitions, announcements of changes in the company's board of directors or senior management fall under the 'Board/Management Information' category (MANG). The document is an announcement, not a comprehensive report like a 10-K or IR, and it specifically details board composition changes.
2017-01-25 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and announces the annual balance sheet ('Bilan annuel') of a liquidity contract ('contrat de liquidité') with a broker (Gilbert Dupont) as of December 31, 2016, comparing it to the previous semi-annual balance. This is a routine disclosure related to market making/liquidity provision, often required by stock exchange regulations or agreements. It is not a full Annual Report (10-K), an Earnings Release (ER) detailing operational results, or a formal Audit Report (AR). Since it is a specific, periodic regulatory disclosure concerning market operations and financial arrangements, and it doesn't fit perfectly into the other specific categories (like DIV, CAP, or DIRS), it falls best under the general regulatory announcement category, RNS, or potentially a specialized filing if one existed for liquidity contracts. Given the provided definitions, RNS (Regulatory Filings) is the most appropriate fallback for a specific, non-core financial announcement that isn't a major report or earnings release. The document length (5591 chars) is substantial enough that it's not just a placeholder announcement (RPA), but a substantive update.
2017-01-04 French
Communicated under the obligation to provide permanent information / Other communications
Legal Proceedings Report Classification · 1% confidence The document is explicitly titled '# PRESS RELEASE' and provides an update on a clinical study ('Update on the PIVOTAL study on the CARMAT bioprosthetic artificial heart'). It contains company commentary, background information, and contact details typical of a formal announcement intended for immediate public dissemination, rather than a comprehensive regulatory filing like a 10-K or IR. Since it is a press release announcing specific operational/clinical progress, it fits best under the general 'Regulatory Filings' (RNS) category, as it is a broad regulatory/public disclosure that doesn't match the more specific categories like ER (Earnings Release), LTR (Legal), or DIV (Dividend). Given the length (5740 chars), it is not a short RPA.
2016-11-30 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and details an update regarding the PIVOT study for CARMAT's artificial heart, specifically reporting the death of the first patient and confirming the device was not implicated. This format—a brief, timely announcement of material, non-financial operational news (a clinical trial update)—is characteristic of an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it is not a full financial report (10-K, IR), a management discussion (MDA), or a formal voting result (DVA), and it is a direct announcement of a significant event, it fits best as an Earnings Release (ER) if it were quarterly results, but since it is a specific operational/clinical update, it is often categorized as a general regulatory announcement or press release. Given the options, and recognizing that press releases announcing material operational updates often fall under ER or RNS, I will check the definitions. ER is for 'initial announcement of quarterly/periodical financial results (key highlights only)'. This is not financial results. RNS is the 'General regulatory announcements and fallback category for miscellaneous filings'. Since this is a press release announcing a critical clinical trial event, RNS is the most appropriate fallback for a non-standard, material announcement that isn't explicitly defined elsewhere (like DIRS, MANG, or LTR). The document length (6093 chars) is substantial enough that it is the report itself, not just an announcement of a report (RPA). Therefore, RNS is the best fit.
2016-11-30 French
Rapport financier semestriel
Interim / Quarterly Report Classification · 1% confidence The document is titled 'RAPPORT FINANCIER SEMESTRIEL 2016' (Semi-annual Financial Report 2016) for the period ending June 30, 2016. It contains comprehensive financial statements (balance sheet, income statement), management's discussion and analysis (Rapport d'activité), and notes to the financial statements. It is a formal interim report, not an announcement or a summary, and it includes substantive financial data. H2 2016
2016-10-20 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Report Publication Announcement Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and its main subject is the "Mise à disposition du rapport financier semestriel 2016" (Making available of the 2016 semi-annual financial report). The text explicitly states that the semi-annual financial report has been made available to the public and filed with the AMF (Autorité des Marchés Financiers). Since the document itself is a short announcement informing the market that a specific report (the semi-annual financial report, which corresponds to an Interim/Quarterly Report or IR) has been published, it fits the definition of a Report Publication Announcement (RPA) according to Rule #2 (The 'MENU VS MEAL' Rule). It is not the comprehensive report itself, but the announcement of its availability.
2016-10-20 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.